CDK inhibitor shows promise for inflammatory kidney disease

被引：8

作者：

Clough, J

机构：

来源：

DRUG DISCOVERY TODAY | 2002年 / 7卷 / 15期

关键词：

D O I：

10.1016/S1359-6446(02)02392-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：789 / 790

页数：2

相关论文

共 3 条

[1] Glomerulonephritis
Couser, WG
[J]. LANCET, 1999, 353 (9163) : 1509 - 1515
[2] The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis
Kim, YG
Alpers, CE
Brugarolas, J
Johnson, RJ
Couser, WG
Shankland, SJ
[J]. KIDNEY INTERNATIONAL, 1999, 55 (06) : 2349 - 2361
[3] Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist
Pippin, JW
Qu, QY
Meijer, L
Shankland, SJ
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) : 2512 - 2520